TABLE 1.
PROFAC × 100 (%) | |||
Study (workers/patients) | Reference | All Cancer | Lung Cancer |
U.S.shipyard | Sponsler and Cameron 2005 | 16 | 7 |
Airline crew | Blettner et al. 2002; Band et al. 1996 | 21–29 | 23–72 |
U.S. nuclear | Howe el al. 2004 | 35 | 41 |
Canadian nuclear | Zablotska et al. 2004 | 26 | 19–60 |
Japanese nuclear | Iwasaki el al. 2003 | 6 | 28–57 |
Korean nuclear | Jin et al. 2002 | 21–49 | 34 |
UK nuclear | Carpenter et al. 1998 | 27 | 35–41 |
UKAEA | Atkinson et al. 2004 | 10 | 11 |
Russian nuclear | Khokryakov and Romanov 1994 | 7 | 35 |
Canadian dose registry | Sont et al. 2001 | 21 | 31 |
U.S. fluoroscopy | Howe 1995 | — | 6–18 |
U.S. technologists | Doody etal. 1998 | — | 17–39 |
Japanese technologists | Yoshinaga et al. 1999 | — | 38–55 |
Indoor radon | Cohen 1995 | — | −20 |
Japanese radon spa | Mifune 1992 | 37 | 45 |
British radiologists | Berrington et al. 2001 | 29 | 26–100 |
U.S. female nuclear | Wilkinson et al. 2000 | 17 | 47 |
Breast cancer patients | Luckey 2003 | — | 50 |
Mayak plutonium | Khokhriakov and Romanov 1996 | — | 47–61 |